Viridian Therapeutics, Inc. (VRDN)
22.37
-0.45
(-1.97%)
USD |
NASDAQ |
Oct 23, 16:00
22.36
0.00 (0.00%)
After-Hours: 20:00
Viridian Therapeutics Price : 22.37 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 22.75 | 22.75 | 21.92 | 22.37 | 1.179M |
| Oct 22, 2026 | 23.00 | 23.59 | 22.66 | 22.82 | 1.546M |
| Oct 21, 2026 | 22.50 | 23.29 | 22.46 | 23.01 | 1.921M |
| Oct 20, 2026 | 21.10 | 22.68 | 20.85 | 22.43 | 1.975M |
| Oct 19, 2026 | 19.23 | 20.88 | 19.07 | 20.80 | 2.576M |
| Oct 16, 2026 | 19.67 | 19.78 | 18.94 | 19.03 | 2.457M |
| Oct 15, 2026 | 18.69 | 19.78 | 18.54 | 19.56 | 2.168M |
| Oct 14, 2026 | 18.19 | 18.74 | 18.01 | 18.38 | 3.734M |
| Oct 13, 2026 | 18.04 | 18.33 | 17.96 | 18.22 | 2.124M |
| Oct 12, 2026 | 19.00 | 19.18 | 18.21 | 18.30 | 1.947M |
| Oct 09, 2026 | 18.31 | 18.72 | 18.16 | 18.66 | 1.334M |
| Oct 08, 2026 | 18.02 | 18.44 | 17.59 | 18.34 | 2.444M |
| Oct 07, 2026 | 18.02 | 18.73 | 17.92 | 18.28 | 1.691M |
| Oct 06, 2026 | 19.00 | 19.13 | 18.07 | 18.22 | 2.197M |
| Oct 05, 2026 | 19.41 | 19.59 | 18.83 | 19.00 | 2.651M |
| Oct 02, 2026 | 19.16 | 19.54 | 18.92 | 19.40 | 1.515M |
| Oct 01, 2026 | 20.61 | 20.61 | 18.99 | 18.99 | 3.375M |
| Sep 30, 2026 | 20.27 | 20.74 | 20.00 | 20.59 | 1.405M |
| Sep 29, 2026 | 20.68 | 20.85 | 19.73 | 20.00 | 1.234M |
| Sep 28, 2026 | 20.31 | 20.70 | 20.03 | 20.57 | 1.339M |
| Sep 25, 2026 | 20.75 | 21.00 | 20.16 | 20.47 | 2.091M |
| Sep 24, 2026 | 21.10 | 21.25 | 20.22 | 20.66 | 2.211M |
| Sep 23, 2026 | 22.11 | 22.18 | 21.20 | 21.43 | 2.858M |
| Sep 22, 2026 | 22.02 | 22.33 | 21.54 | 22.12 | 1.457M |
| Sep 21, 2026 | 22.28 | 22.40 | 21.53 | 21.58 | 1.746M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Vertex Pharmaceuticals, Inc. | 523.93 |
| TG Therapeutics, Inc. | 54.17 |
| Travere Therapeutics, Inc. | 50.08 |
| ACADIA Pharmaceuticals, Inc. | 19.73 |
| Alnylam Pharmaceuticals, Inc. | 224.03 |
Price Related Metrics
| PS Ratio | 30.37 |
| Price to Book Value | 4.491 |
| Earnings Yield | -16.58% |
| Market Cap | 2.533B |